A Market Place Research – Page 2658

Packaging Machinery Market 2021 Attractiveness, Competitive Landscape and Key Players

The packaging machinery market has witnessed significant growth over the past decade, owing to the rise in investment in various end-user industries such as pharmaceuticals, healthcare, chemicals, and others. A number of players are expanding their business around the globe, owing to increased customer base, enhanced effective operations, developed product portfolios, and expanded geographical reach. This is anticipated to fuel the demand for the packaging machinery

global packaging machinery market size was valued at $43,520.0 million in 2020, and is projected to reach $69,218.0 million by 2030, registering a CAGR of 4.7% from 2021 to 2030

The development of packaging technology has witnessed significant growth over the last decade. Packaging has become one of the essential processes before offering the final product to consumers. The primary applications of packaging machinery are in a wide range of industries across food & drink, healthcare, cosmetics, and other consumer goods as well as a range of industrial sectors where packaging has become essential, with its usage increasing broadly in line with the global economy.

Download PDF Sample Copy : https://www.alliedmarketresearch.com/request-sample/2239

Filling machines used in end-user industries vary upon the specific needs of the industry as there is no single type of filling machine available to fill different types of liquid, solid, or powder. Cleaning & sterilizing machine is expected to be the fastest growing machine type segment, growing at a CAGR of 7.3% by 2027. Cleaning machines are used to clean contaminants from bottles prior to the introduction of the product. These machines have wide applications in the food, beverages, and pharmaceutical industries.

Interested in Procure Data? Visit : https://www.alliedmarketresearch.com/purchase-enquiry/2239

By end-user industries, the food & beverage segment dominated the packaging machinery market in 2020 owing to the growth in food & beverage industry during the forecast period. This growth is attributed to the increase in demand from emerging countries due to the rise in consumer income and improvement in living standards. The fastest growing end user for the packaging machinery market is the food & beverages segment, which is expected to grow at a CAGR of 5.1% by 2030. Packaging machinery manufacturers offer a wide range of automated solutions for the cosmetics industry, which offers best packaging solutions for a wide range of products. These packaging free solutions offer eco-friendly and contaminant free packaging. Filling machines used in the cosmetics industry offer a wide range of high quality packaging formats for different products like pouches, strips, tubes, and sachets.

Get detailed COVID-19 impact analysis : https://www.alliedmarketresearch.com/request-for-customization/2239

Key Findings Of The Study

The report provides an extensive analysis of the current and emerging packaging machinery market trends and dynamics.
By end user, the food & beverages segment dominated the packaging machinery market, in terms of revenue in 2020 and is projected to grow at a CAGR 5.1% during the forecast period.
By type, the filling machines segment led the packaging machinery market in 2020.
Asia-Pacific region is projected to register the highest growth rate in the coming years.
The key players within the packaging machinery market are profiled in this report, and their strategies are analyzed thoroughly, which help understand the competitive outlook of the packaging machinery industry.

Competition Analysis

Aetna Group S.p.A., B&H Manufacturing Company, Inc., Barry-Wehmiller Companies, Inc., CKD Corporation, Coesia S.p.A., Duravant LLC, Fuji Machinery Co., Ltd., Langley Holdings, PLC, Robert Bosch GmbH, and The Adelphi Group of Companies.

Hacksaw Blades Market Analysis, Trend and Forecast, 2021–2030 | Allied Market Research

The growth of the hacksaw blades market is majorly driven by rise in urbanization and rapid industrialization in emerging countries. Asia-Pacific dominated the hacksaw blades market in 2020, owing to presence of large-scale production facilities in countries such as China and India

hacksaw blades market size was valued at $0.9 billion in 2020, and is expected to reach $ 1.5 billion by 2030, registering a CAGR of 4.7% from 2021 to 2030.

However, laser cutting technology and water cutting technology consume less time and power compared to tradition hacksaws and can cut wood and metal into complex shapes, which restrain the growth of the hacksaw blades market. Furthermore, the outbreak of COVID-19 has led to halt in logistic and manufacturing activities across the globe, which, in turn, has led to interruption of supply chain, thereby hindering growth of the hacksaw blades market. However, this situation is expected to improve as government is relaxing norms around the world for resuming business activities.

Download PDF Sample Copy : https://www.alliedmarketresearch.com/request-sample/8629

Rise in utilization of hacksaw blades within the process of sawmill manufacturing is one of the prominent factors driving the growth of the global hacksaw blades market. In addition, rise in demand for furniture in newly constructed infrastructures as well as in renovated buildings has boosted the production of wood cut into pieces through sawmill, which, in turn, contributes toward the market growth. In addition, rapid industrialization has led to increased infrastructural spending on machinery, which propels the hacksaw blades market growth

Interested in Procure Data? Visit : https://www.alliedmarketresearch.com/purchase-enquiry/8629

The hacksaw blade is made of nitrated steel, cast iron, aluminum brass, and stainless steel. The teeth on the hacksaw blades are the major cutting elements on the blades. These blades are fixed in a hacksaw under tension in a frame and used for cutting materials such as metal, wood, and plastic. The hacksaw blades are available in 10 TPI, 14 TPI, 18TPI, 24 TPI, and 32 TPI range. These hacksaws are manually and electrically operated and used by DIY and professional consumers.

Get detailed COVID-19 impact analysis : https://www.alliedmarketresearch.com/request-for-customization/8629

KEY FINDINGS OF THE STUDY

By consumer type, the professionals segment was the highest revenue contributor in 2020.
Depending on thread per inch, the others segment dominated the market in 2020.
On the basis of application, the manual hacksaw led the market in 2020.
Region, Asia-Pacific generated the highest revenue in 2020.

Competition Analysis

Apex Tool Group LLC, Chronos, Disston Company, Gedore, HABUR-SAWS GmbH, Klein Tools, Inc., Snap-on Incorporated, Stanley Black & Decker, Inc., Starrett, and Thomas Flinn & Co. Major.

Industrial Heating Equipment Market Size, Share, Trend and Forecast to 2030

global industrial heating equipment Industry Report 2020 is a professional and in-depth survey on the current state of the industrial heating equipment Market. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The industrial heating equipment Market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status

The industrial heating equipment market was valued at $36.9 billion in 2020, and is expected to reach $64.1 billion by 2030, registering a CAGR of 5.8% from 2021 to 2030. The industrial heating equipment market consists of revenue generated by sales of boilers, furnaces and heat pumps in industries such as oil & gas, metal & mining, chemical and other industries. In addition, these industrial heating equipment requires timely maintenance. Revenue generated by sales of spare parts and maintenances is also included in the industrial heating equipment market.

Get PDF Sample Copy : https://www.alliedmarketresearch.com/request-sample/8634

However, the fossil fuels used in operating these industrial heating equipment emit a large amount of by-products which act as pollutant to the environment and cause climatic imbalance. This has led to implementation of stringent government regulations toward environmental pollution, which restricts the use of industrial heating equipment and acts as restraint to the market. In addition, outbreak of COVID-19 has led to halt in construction and manufacturing activities across the globe. Halt in logistics services has led to halt in the construction industry, which, in turn, hinders the growth of the industrial heating equipment market. However, industries are gradually back on track and vaccine discovery has led to recovery of the industrial heating equipment market by mid-2021. On the contrary, advanced research and introduction of sustainable solutions such as, use of geothermal heat pump technology will act as a major opportunity for the growth of the industrial heating equipment market during the forecast period.

The industrial heating equipment market is driven by rise in demand for steam boilers from various end-use industries such as chemical, pharmaceutical and others. With industrialization and urbanization in emerging countries in LAMEA and Asia-Pacific region, demand for steam boilers has significantly increased in the past few years. In addition, increase in investment by the governments and large scale manufacturers toward adding power generation capacity has also surged the demand for industrial heating equipment in the market and in turn is leading to the industrial heating equipment market growth.

Get detailed COVID-19 impact analysis : https://www.alliedmarketresearch.com/request-for-customization/8634

The industrial heating equipment market is segmented on the basis of product type, fuel type, end-user industry and region. On the basis of product type, the market is divided into heat pumps, furnaces and boilers. On the basis of fuel type, the market is divided into fossil fuel and electric. Depending on end-user industry, it is classified into oil & gas, metal & mining, chemical and others. By region, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, France, Spain and rest of Europe), Asia-Pacific (China, Japan, South Korea, India, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).

Market players : Carrier, Easco Boiler Corp., Emerson Electric Co., Ingersoll Rand Inc., Johnson Controls, Inc., Lennox International Inc., McKenna Boiler Works Inc., The Danfoss Group, Thermcraft, Inc. and Uponor Corporation.

Interested in Procure Data? Visit: https://www.alliedmarketresearch.com/purchase-enquiry/8634

Reverse Vending Machine Market 2030 Growth Opportunities, Top Key Players, Industry Outlook and Forecasts

the global reverse vending machine market has witnessed significant growth in the past decade, owing to rise in amount of waste generated, rise in environmental awareness among population. In addition, government regulations towards illegal dumping drives the market growth. However, fluctuation in raw material prices is anticipated to hamper the growth of the market. Technological advancements such as Artificial Intelligence (AI), and Internet of Things (IoT) in the reverse vending machines, which provide lucrative opportunities for the reverse vending machine growth

The global reverse vending machine market size was valued at $0.37 billion in 2020, and is expected to reach $0.73 billion by 2030, with a CAGR of 6.6% from 2021 to 2030. In 2020, Asia-Pacific region dominated the global market, in terms of revenue, accounting for around half share of the global reverse vending machine

Download PDF Sample Copy : https://www.alliedmarketresearch.com/request-sample/13149

The global reverse vending machine market is segmented on the basis of product type, capacity, end user, and region. On the basis of product type, the market is divided into non-refillable, refillable, and multifunctional. Non-refillable segment generated the highest revenue in 2020. Based on capacity, the market is divided into less than 200 cans, 200-300 cans, 300-600 cans, and more than 600 cans. More than 600 cans segment dominated the market in 2020. On the basis of end user, the market is categorized into supermarkets, communities, and utilities. Supermarkets segment generated the highest revenue in 2020.

Growth in the foods & beverages industry across the globe, which is expected to rise increase the in amount of waste generated from population, is expected to propel demand for reverse vending machines for to collect and disposable of waste, fuels the growth of the global reverse vending machine market. For instance, the food & beverages industry globally is expected to grow at a rate of 48.1% from 2020 to 2022. However, fluctuation in raw material prices, and high cost of reverse vending machines, are anticipated to restraints for the growth of the global reverse vending machine. Contrary, technological advancements in reverse vending machines such as AI powered machine, touch screen panel, and others, are anticipated to provide lucrative opportunities for the growth of the global reverse vending machine market.

Interested in Procure Data? Visit : https://www.alliedmarketresearch.com/purchase-enquiry/13149

Major players such as Teraoka Seiko Co Ltd, Tomra Sorting GmbH, and Aco Recycling are some of the players engaged in offering reverse vending machine to the market. For instance, Teraoka Seiko Co Ltd offers DRV-100 reverse vending machine. It is capable of accept PET plastic drink bottles. It is used for industries such as retail, food industry, logistics, and hospitality sectors. It has features such as easy to install, easy to operate, and higher storage capacity.

Get detailed COVID-19 impact analysis : https://www.alliedmarketresearch.com/request-for-customization/13149

Key Findings Of The Study

The report provides an extensive analysis of the current and emerging global reverse vending machine market trends and dynamics.
By product type, non-refillable segment dominated the market, in terms of revenue in 2020, and refillable segment is projected to grow at a CAGR of 6.9% during the forecast period.
By capacity, more than 600 cans segment registered highest growth in the global reverse vending machine market share in 2020.

Competition Analysis

Sielaff GmbH & Co KG, Ake Environmental Technologies, Envipco Holding N.V., Endlos Innovations Private Limited, Tomra Sorting GmbH, Diebold Nixdorf, RVM Systems, Aco Recycling, Kansmacker Mfg, and Teraoka Seiko Co Ltd.

Cell Therapy Processing Market Growth Factors, Opportunity Growth, Development and Key Manufacturer Analysis Report 2022-2026

Increase in the incidence of cardiovascular diseases and surge in the demand for chimeric antigen receptor (CAR) cell therapy propel the global cell therapy processing market. However, poor demand from underdeveloped countries hinders the market growth. On the other hand, emerging markets are expected offer lucrative opportunities in the near future.

According to the report published by Allied Market Research, the global cell therapy processing industry garnered $1.69 billion in 2018, and is estimated to reach $12.06 billion by 2026, growing at a CAGR of 27.8% from 2019 to 2026. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

Request Sample Report at https://www.alliedmarketresearch.com/request-sample/6446

Onkar Sumant, a Manager, Healthcare at Allied Market Research, stated, The growth of the cell therapy processing market is attributed to increase in the incidence of cardiovascular diseases. Furthermore, rise in the demand for chimeric antigen receptor (CAR) t cell therapy, and increase in the development of stem cell therapy approaches globe are the other factors that contribute to the growth of the cell therapy processing market.

Cell therapy is the transplantation of human cells to replace or repair damaged tissue or cells. With new technologies, innovative products and limitless imagination, many different types of cells may be used as part of a therapy or treatment for a variety of diseases and conditions. Some of the cells that may be used include mesenchymal stem cells, dendritic cells, hematopoietic stem cells, skeletal muscle stem cells, lymphocytes and pancreatic islet cells.

North America to maintain its dominance during the forecast period

Based on region, North America accounted for the highest market share in terms of revenue, accounting for nearly two-fifths of the global cell therapy processing market in 2018, and is estimated to maintain its dominance during the forecast period. This is attributed to presence of well-established healthcare infrastructure, higher buying power, and surge adoption of advanced medical therapies. In addition, rise in prevalence of osteoporosis coupled with surge in geriatric population fuels the growth of the market in this region. Moreover, Asia-Pacific is expected to maintain the highest CAGR of 29.0% from 2019 to 2026, owing to presence of huge patient base, increase in research and development expenditure, and surge in usage of cell therapy processing products.

For Purchase Enquiry at https://www.alliedmarketresearch.com/purchase-enquiry/6446

Leading market players

Invitrx Inc.
Cell Therapies Pty Ltd
Lonza Ltd
Merck & Co., Inc (FloDesign Sonics)
NantWorks, LLC
Neurogeneration, Inc.
Novartis AG
Plasticell Ltd.
Regeneus Ltd
StemGenex, Inc.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.

Contact us:

David Correa

5933 NE Win Sivers Drive

#205, Portland, OR 97220

United States

Toll Free: 1-800-792-5285 |UK: +44-845-528-1300 | Hong Kong: +852-301-84916 | India (Pune): +91-20-66346060 | Fax: +1-855-550-5975 Email” help@alliedmarketresearch.com
Follow us on LinkedIn, Facebook, Twitter, Pinterest, YouTube & Instagram

Healthcare CRO Services Market Trends And Opportunity. Latest Research Report Growth And Status Explored In A New Research By 2026

Rise in R&D investment and significant increase in cancer incidence across the globe have boosted the growth of the global healthcare CRO services market. However, dearth of skilled healthcare professionals hampers the market growth. On the contrary, various growth opportunities in emerging economies would further propel the market growth.

According to the report published by Allied Market Research, the global healthcare CRO services market size is expected to reach $66,036.80 million by 2026, registering a CAGR of 6.9% from 2019 to 2026, in terms of value. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/6443

Significant increase in R&D for the development of drugs & medical devices and increase in private biotechnology organizations are the major factors driving the growth of healthcare CRO services market. Moreover, surge in healthcare expenditure and rise in government initiatives toward promoting R&D in the field of biotechnology propels the healthcare CRO services market growth. However, penetrating competition in the market and dearth of skilled professionals are the major factors anticipated to hamper the growth of healthcare CRO services market. Moreover, rise in the biotech and pharmaceutical sector in developing economies is expected to create lucrative opportunities in the future.

Onkar Sumant, a Manager, Healthcare at Allied Market Research, stated, Growth in R&D in the biotechnology and pharmaceutical sector across the globe and rise in adoption by key players to enter into contracts with CRO service providers is anticipated to drive the healthcare CRO services market growth.

North America held the lion’s share

Based on geography, the market across North America held the largest share in 2018, contributing to nearly half of the total revenue, owing to rise in biotechnology and pharmaceutical research by industry giants in the region. However, the global healthcare CRO services market across Asia-Pacific is anticipated to manifest the fastest CAGR of 7.4% during the study period, due to rise in demand for healthcare CRO services.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6443

Major market players

IQVIA
ICON
PRA Health Sciences
Evotec
Syneos
Medpace
Charles River
Labcorp
Syngene
Biotelemetry

Avenue Basic Plan | Library Access | 1 Year Subscription |

About Allied Market Research:

Contact us:

David Correa

5933 NE Win Sivers Drive

#205, Portland, OR 97220

United States

Otorhinolaryngology Devices Market Future Scenarios, Growth and Analytical Insights and Leading Global Companies 2022-2026

High prevalence of chronic sinusitis, increase in adoption of minimally invasive ENT procedures, and rise in elderly population drive the growth of the global otorhinolaryngology devices market. However, limited awareness and high costs, and government regulations and reimbursement issues hamper the growth to certain extent. On the contrary, high growth prospects in emerging market would open new opportunities for the market players.

According to the report published by Allied Market Research, the global otorhinolaryngology devices market size was valued at $9,268 million in 2018, and is projected to reach $13,999 million by 2026, registering a CAGR of 5.2% from 2019 to 2026. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

Request Sample Report at:

https://www.alliedmarketresearch.com/request-sample/6400

Onkar Sumant, a Manager, Healthcare at Allied Market Research, stated, “The growth of the global otorhinolaryngology devices market is majorly attributable to rise in prevalence of ear, nose, and throat diseases. In addition, increase in adoption of innovative otorhinolaryngology devices such as capsule endoscopes and robot-assisted otorhinolaryngology surgery along with ultra-high-definition visualization systems is anticipated to boost the market growth in the coming years.”

Key Findings of the Study:

Based on product, the surgical devices segment was the second major revenue contributor in 2018, and is anticipated to continue this trend during the forecast period.
Depending on end user, the others end user segment is expected to exhibit the highest CAGR with 5.5% during the forecast period.
By region, North America was the largest revenue contributor in 2018, and is expected to continue this trend from 2019 to 2028.
U.S. generated the highest revenue in the global otorhinolaryngology devices market in 2018, accounting for more than one-third of the global market in 2018.
Asia-Pacific is anticipated to grow at a highest CAGR during the forecast period.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6400

North America garnered largest share

The market across North America accounted for the largest share in 2019, garnering nearly two-fifths of the market. Rise in the adoption of otorhinolaryngology devices for ear, nose, and throat interventions, innovations, and introduction of advanced technologies propel the growth of the market in this region. However, the global otorhinolaryngology devices market across Asia-Pacific is estimated to register the highest CAGR of 6.8% during the study period, due to rise in number of expansion activities by top players, increase in geriatric population, and surge in prevalence of cataract.

Major market players

Freudenberg SE (InHealth Technologies, Inc.)
Hill-Rom Holdings, Inc
Atos Medical AB, Cochlear Ltd
Johnson & Johnson (Acclarent, Inc.)
Medtronic Plc.
Olympus Corporation
Sonova Group
Starkey Hearing Technologies
Stryker Corporation

Psoriatic Arthritis Treatment Market Trends and Global Demand and Upcoming Opportunities (2022-2026)

What is the most common treatment for psoriatic arthritis?

Treatment focuses on controlling inflammation in your affected joints to prevent joint pain and disability and controlling skin involvement. One of the most common treatments are prescription medications called disease-modifying antirheumatic drugs (DMARDs).

Rise in prevalence of psoriasis & psoriatic arthritis disease, increase in number of pipeline drugs, and surge in government expenditure on healthcare have boosted the growth of the global psoriatic arthritis treatment market. However, poor demand in under-developed countries hampers the market. On the contrary, growth potential in the emerging market is expected to create lucrative opportunities in the near future.

Request Sample Report at:

https://www.alliedmarketresearch.com/request-sample/6316

Market Value & CAGR:

The psoriatic arthritis treatment market size was valued at $7,860 million in 2018, and is estimated to reach at $13,744 million by 2026, registering a CAGR of 7.2% from 2019 to 2026.

Biologics segment dominated the market

By drug type, the biologics segment held the largest share in 2018, contributing to more than three-fifths of the global psoriatic arthritis treatment market. Moreover, the segment is expected to register the fastest CAGR of 7.9% during the forecast period. This is due to surge in patient awareness toward the availability of DMARDs drugs for psoriatic arthritis treatment, rise in prevalence of psoriatic arthritis, presence of biologics &biosimilars, and increase in healthcare expenditure in developed regions. The report includes an in-depth analysis other segments such as NSAIDs, DMARDs, and other.

Onkar Sumant, a Manager, Healthcare at Allied Market Research, stated, The growth of the psoriatic arthritis treatment market is attributed to rise in prevalence of psoriasis & psoriatic arthritis disease across the globe. Furthermore, surge in demand for novel treatments coupled with increase in number of pipeline drugs for psoriatic arthritis treatment is the major factors that contributes toward the growth of the global market.

According to route of administration, the psoriatic arthritis treatment market is fragmented into topical, oral, and injectable. Presently, the oral segment is the major shareholder in the global psoriatic arthritis treatment market, owing to rise in demand for oral psoriatic arthritis treatment drugs, increase in awareness toward availability of psoriatic arthritis treatment, surge in R&D activities to develop new drugs, rise in consumption of oral psoriatic arthritis treatment drugs, and low cost of oral NSAIDs drugs. In addition, rise in healthcare budgets of developed & developing countries is expected to offer remunerative opportunities for psoriatic arthritis treatment market expansion in the near future.

For Purchase Enquiry at:https://www.alliedmarketresearch.com/purchase-enquiry/6316

Major market player

AbbVie Inc.
Bristol-Myers Squibb Company
Amgen Inc.
Eli Lilly And Company
Celgene Corporation
Merck & Co Inc.
Johnson & Johnson
Pfizer Inc.
Novartis AG
UCB S.A.

About Allied Market Research:

Contact us:

David Correa

5933 NE Win Sivers Drive

#205, Portland, OR 97220

United States

Anti-Rheumatics Market Competitive Analysis Segmentation & Strategy Framework, Prospects 2026

Rise in prevalence of rheumatoid arthritis, increase in elderly population, and surge in incidence of obesity worldwide fuel the growth of the global anti-rheumatics market. On the other hand, side effects related to the medication and higher cost of biologics & biosimilars curtail down the growth to certain extent. However, R&D activities in the field of biosimilars and novel biologics are expected to pave the way for multiple opportunities in the industry.

According to the report published by Allied Market Research, the global anti-rheumatics industry accounted for $57.22 billion in 2018, and is estimated to reach $71.93 billion by 2026, growing at a CAGR of 2.9% from 2019 to 2026. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

Request Report Sample at: https://www.alliedmarketresearch.com/request-sample/6289

Onkar Sumant, a Manager, Healthcare at Allied Market Research, stated, The demand for anti-rheumatics is on the rise, owing to surge in incidence of rheumatoid arthritis worldwide. Furthermore, surge in geriatric population across the globe is another major factor that fuels the growth of the market.

In 2018, North America accounted for the major share of anti-rheumatics market size and is expected to remain dominant, owing to easy availability of the anti-rheumatics in this region. Moreover, surge in geriatric population in the region is another major factor that fuels the growth of anti-rheumatic market. On the other side, Asia-Pacific is estimated to register the fastest growth during the forecast period, owing to surge in awareness related to the use of anti-rheumatics.

The prescription-based drugs segment to maintain its dominance by 2026

Based on type, the prescription-based drugs segment accounted for the highest share in the global anti-rheumatics market in 2018, contributing for more than three-fourths of the total share, and is estimated to maintain its dominance in terms of revenue throughout the forecast period. This is due to increase in the number of specialized hospitals across the world that provide treatment from specialized medical professionals. However, the over-the-counter drugs segment is estimated to register the highest CAGR of 3.3% from 2019 to 2026, owing to surge in awareness related to treatment options and ease in availability.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6289

Leading market players

Pfizer, Inc.
Johnson & Johnsons
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd.
Celegene Corporations
MedImmune, LLC
Takeda Pharmaceutical Company Ltd.
Biogen Inc.
Celltrion Inc.
Amgen Inc.

About Allied Market Research:

Contact us:

David Correa

5933 NE Win Sivers Drive

#205, Portland, OR 97220

United States

T-Cell therapy Market | Juno Therapeutics, Kite Pharma, Adaptimmune, Tmunity Therapeutics and GigaGen

T-cell therapy is a form of immunotherapy that uses specially altered T cells — a part of the immune system — to fight cancer. A sample of a patient’s T cells are collected from the blood, then modified to produce special structures called chimeric antigen receptors (CARs) on their surface. When these T cells are reinfused into the patient, the new receptors enable them to latch onto a specific antigen on the patient’s tumor cells and kill them.Currently, T-cell therapy is FDA approved as standard of care for some forms of aggressive, relapsed or refractory non-Hodgkin lymphoma, including diffuse large B cell lymphoma, primary mediastinal B-cell lymphoma, high grade B-cell lymphoma, transformed follicular lymphoma, and mantle cell lymphoma. In addition, T-cell therapy is approved for patients with relapsed or refractory acute lymphoblastic leukemia up to age 25. There are also many clinical trials of T-cell therapy for other types of blood cancer and solid tumors.Download PDF Sample Report: https://www.alliedmarketresearch.com/request-sample/10893

COVID-19 scenarioanalysis:

Pharmaceutical and biotechnological companies together with governments around the globe are working to combat with the COVID-19 outbreak, from supporting the development of vaccines to schedule for medicines supply chain challenges. Furthermore, there are around 115 vaccine candidates and other 155 molecules that are kept in the R&D pipeline in the coming years. Moreover, commonly used drugs, such as hydroxychloroquine, have witnessedhugeboost in demand for the management of COVID-19. Increase in demand for drugs had presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Attributedto the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is anticipated to witness a substantial growth in the next few years.

Top impacting factors: Market scenario analysis, trends, drivers, and impact analysis

The major factor affecting the industry includesincrease inapplication of T-cell therapeutic immunity system. In addition, growth in the number of cancer patients globally would help the industry propel during the forecast period.Variation in disease patterns and the surge in awareness programs among the population are anticipated to help the industry gain traction in the next few years.Favorable reimbursement policies &strictregulations and applicability of T-cell therapies in various research centers mainly focusing on cancer treatmentare expected to boost the growth of the industry over the forecast period.

Growth in the number of products launches to boost the T-Cell therapy market

Increase in number of products launches due to high demand from the population is anticipated to propel the growth of the industry in the next few years. For instance, in July 2020, the U.S. Food and Drug Administration approved Tecartus (brexucabtagene autoleucel), a cell-based gene therapy for treatment of adult patients diagnosed with mantle cell lymphoma (MCL) who have not responded to or who have relapsed following other kinds of treatment. Tecartus, a chimeric antigen receptor (CAR) T cell therapy, is the first cell-based gene therapy approved by the FDA for the treatment of MCL.

Furthermore, in June 2019, Proteona Pte. Ltd. launched its latest ESCAPE proteogenomics assay designed specifically for Chimeric Antigen Receptor (CAR)T cell characterization. This is the first commercial product designed to characterize both RNA and protein expression levels across thousands of single CART cells. Through the use of simultaneous gene and protein expression analysis, the ESCAPE CAR T assay is able to identify CAR positive cells, measure changes in cytokine expression,deeply phenotype cells through measuring the expression of 25 key cell surface proteins, and discover new gene expression patterns important for research. Together with Proteona’s state-of-the-art data analysis support, the ESCAPE CAR T assay provides rich information that can be used at all stages of the CAR T workflow from initial cell collection to post infusion patient monitoring.

Key segments covered:

Type

Hematologic Malignancies
Solid Tumors

Type of Imaging

TCR Therapy
CAR T-Cell Therapy
TIL Therapy

Key benefits of the report:

This study presents the analytical depiction of the global T-Cell therapymarketalong with the current trends and future estimations to determine the imminent investment pockets.
The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global T-Cell therapymarket share.
The current market is quantitatively analyzed from 2020 to 2027 to highlight the global T-Cell therapymarket growth scenario.
Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
The report provides a detailed global T-Cell therapymarket analysis based on competitive intensity and how the competition will take shape in coming years.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/10893

Similar Reports:

Dental Consumables Market

Sports Medicine Market

About Us

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.